File(s) under permanent embargo
Medical travel and the sale of human biological materials: suggestions for ethical policy development
The international medical travel industry includes patients seeking to access human biological materials (HBM) including gametes, organs and stem cells. Of the various niche markets, ‘transplant tourism’ has earned global condemnation and efforts to eradicate cross-border trade in organs, while other markets continue to expand. This article reviews the ethical issues raised by medical travel for HBM, in particular those concerning trade in HBM. It argues that a more consistent approach to the regulation of cross-border trade is imperative to ensure that the perils of ‘transplant tourism’ are not replicated in other markets. In addition, it discusses the role of the self-sufficiency model in assisting the development of ethical and practical policies regarding the procurement and use of human biological materials at a national level, thereby minimizing demand for medical travel.
History
Journal
Global social policyVolume
10Issue
3Pagination
377 - 395Publisher
SageLocation
London, EngPublisher DOI
ISSN
1468-0181eISSN
1741-2803Language
engPublication classification
C Journal article; C1.1 Refereed article in a scholarly journalCopyright notice
2010, The AuthorsUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC